SIOUX FALLS, SD (KSFY) - Sanford Health has received a $25 million donation from T. Denny Sanford that will fund the Pharmacogenomics Action for Cancer Survivorship.
The project is set to launch this year in Durham, North Carolina and eventually expand to 125 sites by 2022. While the initial patients will be cancer survivors, they will eventually grow to 250,000 U.S. veterans.
“This will be the largest pharmacogenetic testing effort in the country by orders of magnitude,” said Dr. Deepak Voora, M.D., Director, VA PHASeR Program Associate Professor, Department of Medicine, Center for Applied Genomics & Precision Medicine, Duke University School of Medicine. “We have the potential to improve patient care for each veteran we test, and the scale of the effort will allow us to see trends and conduct research that could improve medical care for the entire population.”
The testing conducted will help find the most effective medications for patients by giving them better treatments that involve less negative drug reactions.
“This testing will help providers at the VA prescribe the most appropriate medications at the right dose,” said Veterans Administration Secretary Robert Wilkie. “Our goal is take care of our nation’s veterans.”
Sanford says the program will eventually support genetic counseling for patients.